{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:22:32Z","timestamp":1794244952162,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejmech.2024.116221","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T04:39:46Z","timestamp":1707971986000},"page":"116221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Design, synthesis and biological evaluation of thiazolyl-halogenated pyrroles or pyrazoles as novel antibacterial and antibiofilm agents"],"prefix":"10.1016","volume":"268","author":[{"given":"Yuanchen","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-5808","authenticated-orcid":false,"given":"Chunhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116221_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fcimb.2019.00074","article-title":"Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, quorum-sensing interference and biofilm inhibition","volume":"9","author":"Fleitas Martinez","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116221_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111743","article-title":"Recent development of membrane-active molecules as antibacterial agents","volume":"184","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116221_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmic.2023.100084","article-title":"Biofilms: understanding the structure and contribution towards bacterial resistance in antibiotics","volume":"16","author":"Shree","year":"2023","journal-title":"Med. Microecol."},{"key":"10.1016\/j.ejmech.2024.116221_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BJ20141251","article-title":"Mechanisms of biofilm inhibition and degradation by antimicrobial peptides","volume":"468","author":"Segev-Zarko","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116221_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106551","article-title":"Quorum sensing inhibitors as Therapeutics: bacterial biofilm inhibition","volume":"136","author":"Vashistha","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","article-title":"Targeting microbial biofilms: current and prospective therapeutic strategies","volume":"15","author":"Koo","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116221_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114309","article-title":"Design, synthesis, and biological evaluations of substituted pyrazoles as pyrrolomycin analogues against staphylococcal biofilm","volume":"236","author":"Huan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115867","article-title":"Synthetic non-toxic anti-biofilm agents as a strategy in combating bacterial resistance","volume":"262","author":"Hassan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib10","doi-asserted-by":"crossref","first-page":"21658","DOI":"10.3390\/molecules201219797","article-title":"Pharmaceutical potential of synthetic and natural pyrrolomycins","volume":"20","author":"Cascioferro","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116221_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01450-19","article-title":"Pyrrolomycins are potent natural protonophores","volume":"63","author":"Valderrama","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116221_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/antibiotics9060292","article-title":"New synthetic nitro-pyrrolomycins as promising antibacterial and anticancer agents","volume":"9","author":"Raimondi","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2024.116221_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijantimicag.2004.11.014","article-title":"3,4,5,3',5'-Pentabromo-2-(2'-hydroxybenzoyl)pyrrole: a potential lead compound as anti-Gram-positive and anti-biofilm agent","volume":"25","author":"Schillaci","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2024.116221_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmech.2016.08.017","article-title":"Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents: design, synthesis, pharmacokinetics and antibacterial activities","volume":"124","author":"Yang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115689","article-title":"Thiazole-based analogues as potential antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA) and their SAR elucidation","volume":"259","author":"Guo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1248\/cpb.c14-00837","article-title":"Antimicrobial and anti-biofilm activity of thiourea derivatives incorporating a 2-aminothiazole scaffold","volume":"63","author":"Stefanska","year":"2015","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejmech.2024.116221_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/md16080274","article-title":"New thiazole nortopsentin analogues inhibit bacterial biofilm formation","volume":"16","author":"Carbone","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2024.116221_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22111827","article-title":"New 2-phenylthiazoles as potential sortase A inhibitors: synthesis, biological evaluation and molecular docking","volume":"22","author":"Oniga","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116221_bib19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s00044-013-0672-7","article-title":"Synthesis and anti-biofilm activity of thiazole Schiff bases","volume":"23","author":"More","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.116221_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2017.12.076","article-title":"Anti-biofilm effect of novel thiazole acid analogs against Pseudomonas aeruginosa through IQS pathways","volume":"145","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib21","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1021\/acs.jmedchem.5b01678","article-title":"Novel 3-aminothiazolquinolones: design, synthesis, bioactive evaluation, SARs, and preliminary antibacterial mechanism","volume":"59","author":"Cui","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101178","article-title":"Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH","volume":"46","author":"Goedeke","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejmech.2024.116221_bib23","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1021\/acs.jmedchem.7b01182","article-title":"Small molecule mitochondrial uncouplers and their therapeutic potential","volume":"61","author":"Childress","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib24","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1039\/D1MD00230A","article-title":"Design, synthesis, and antibacterial activity ofN-(trifluoromethyl)phenyl substituted pyrazole derivatives","volume":"12","author":"Saleh","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116221_bib25","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(00)04403-2","article-title":"Whole genome sequencing of meticillin-resistant Staphylococcus aureus","volume":"357","author":"Kuroda","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116221_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/147323000503300310","article-title":"Patterns of macrolide resistance determinants among S. Pyogenes and S. Pneumoniae isolates in Saudi Arabia","volume":"33","author":"Shibl","year":"2005","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejmech.2024.116221_bib27","first-page":"217","article-title":"Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management","volume":"8","author":"O'Driscoll","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2024.116221_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nchembio.2003","article-title":"Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence","volume":"12","author":"Chen","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116221_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20072208","article-title":"Vaccine protection against Staphylococcus aureus pneumonia","volume":"205","author":"Wardenburg","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejmech.2024.116221_bib30","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/AAC.01710-09","article-title":"vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium","volume":"54","author":"Xu","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116221_bib31","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1002\/anie.201902210","article-title":"Sulfonium, an underestimated moiety for structural modification, alters the antibacterial profile of vancomycin against multidrug\u2010resistant bacteria","volume":"58","author":"Guan","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.116221_bib32","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1021\/ic990318w","article-title":"Preparation, characterization, and physical properties of bis(imidazole)sulfur difluoride and bis(4-phenylimidazole)sulfur difluoride. New compositions with unexpected thermal stability","volume":"38","author":"Syvret","year":"1999","journal-title":"Inorg. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:02:34Z","timestamp":1759330954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"alternative-id":["S0223523424001016"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116221","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of thiazolyl-halogenated pyrroles or pyrazoles as novel antibacterial and antibiofilm agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116221"}}